BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32989915)

  • 1. Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
    Liu WR; Zhang B; Chen C; Li Y; Ye X; Tang DJ; Zhang JC; Ma J; Zhou YL; Fan XJ; Yue DS; Li CG; Zhang H; Ma YC; Huo YS; Zhang ZF; He SY; Wang CL
    Thorac Cancer; 2020 Nov; 11(11):3234-3242. PubMed ID: 32989915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer.
    Feng M; Ye X; Chen B; Zhang J; Lin M; Zhou H; Huang M; Chen Y; Zhu Y; Xiao B; Huang C; Katz RL; Bai C
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2397-2405. PubMed ID: 33547948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer.
    Qiu X; Zhang H; Zhao Y; Zhao J; Wan Y; Li D; Yao Z; Lin D
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):685-695. PubMed ID: 33893839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].
    Shen Q; Shen LS; Chen Q; Zhou JY; Zhou JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):772-777. PubMed ID: 30347548
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.
    Katz RL; He W; Khanna A; Fernandez RL; Zaidi TM; Krebs M; Caraway NP; Zhang HZ; Jiang F; Spitz MR; Blowers DP; Jimenez CA; Mehran RJ; Swisher SG; Roth JA; Morris JS; Etzel CJ; El-Zein R
    Clin Cancer Res; 2010 Aug; 16(15):3976-87. PubMed ID: 20651054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.
    Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q
    Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
    Su K; Zhang T; Wang Y; Hao G
    World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of isocitrate dehydrogenase 1 as a serum protein biomarker for the early detection of non-small-cell lung cancer: A multicenter in vitro diagnostic clinical trial.
    Sun N; Sun S; Gao Y; Li Y; Lu Z; Yuan Z; Che Y; Huang J; Mao S; Lei Y; Zang R; Li N; Cui W; Qi J; Chen F; Gao J; Wang J; Min R; Chen Y; Shi G; Tan F; He J
    Cancer Sci; 2020 May; 111(5):1739-1749. PubMed ID: 32167618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.
    Zhong Y; Ding X; Bian Y; Wang J; Zhou W; Wang X; Li P; Shen Y; Wang JJ; Li J; Zhang C; Wang C
    Mol Oncol; 2021 Sep; 15(9):2439-2452. PubMed ID: 33340250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatically changed immune-related molecules as early diagnostic biomarkers of non-small cell lung cancer.
    Ye X; Zhang N; Jin Y; Xu B; Guo C; Wang X; Su Y; Yang Q; Song J; Yu W; Cheng P; Cheng L; Gong Y; Fu X; Sun H
    FEBS J; 2020 Feb; 287(4):783-799. PubMed ID: 31482685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
    Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
    Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules.
    Chen C; Huang X; Yin W; Peng M; Wu F; Wu X; Tang J; Chen M; Wang X; Hulbert A; Brock MV; Liu W; Herman JG; Yu F
    Clin Epigenetics; 2020 Mar; 12(1):39. PubMed ID: 32138766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary malate dehydrogenase 2 is a new biomarker for early detection of non-small-cell lung cancer.
    Ma YC; Tian PF; Chen ZP; Yue DS; Liu CC; Li CG; Chen C; Zhang H; Liu HL; Zhang ZF; Chen L; Zhang B; Wang CL
    Cancer Sci; 2021 Jun; 112(6):2349-2360. PubMed ID: 33565687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.